Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Oxford University Hospitals at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Oxford University Hospitals brings 6 presentations to ASH 2026 in New Orleans. Its program centres on lymphoma, myeloma and CLL. Research covers acalabrutinib in older mantle cell lymphoma, CD38 antibody after transplant and MDS progression to acute myeloid leukemia.

OrganizationASH 2026 Attendance
Oxford University Hospitals
Oxford, United Kingdom
Hospitals & cancer centres
NHS teaching hospital trust in Oxford, England, including the John Radcliffe and Churchill hospitals.
Symposium
Fri Dec 11
7:00am–10:00am
Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation
Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention.
Myeloma · New drugs
Talk
Mon Dec 14
4:30pm–5:45pm
Acquired Methemoglobinemia: Who, Why, and What to Do
Exposures that cause acquired methemoglobinemia, such as dapsone, rasburicase, topical anesthetics and recreational nitrites, and how to diagnose and treat it.
Red cells

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Oxford University Hospitals

Tell us what you sell and we’ll find the people at Oxford University Hospitals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction